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RESEARCH ARTICLE

Automated Annotation of Epileptiform
Burden and Its Association with
Outcomes
Sahar F. Zafar, MD ,1† Eric S. Rosenthal, MD ,1† Jin Jing, PhD,1† Wendong Ge, PhD,1†
Mohammad Tabaeizadeh, MD,1,2 Hassan Aboul Nour, MD ,1,3 Maryum Shoukat, MD ,1,4
Haoqi Sun, PhD,1 Farrukh Javed, MD,1,5 Solomon Kassa, MD,1 Muhammad Edhi, MD,1
Elahe Bordbar, MD,6 Justin Gallagher, BA,1 Valdery Moura Jr MSc, MBA,1
Manohar Ghanta, MS,1 Yu-Ping Shao, MS,1 Sungtae An, MS,7 Jimeng Sun, PhD,8
Andrew J. Cole, MD ,1 and M. Brandon Westover, MD, PhD

1,9,10

Objective: This study was undertaken to determine the dose–response relation between epileptiform activity burden
and outcomes in acutely ill patients.
Methods: A single center retrospective analysis was made of 1,967 neurologic, medical, and surgical patients who
underwent >16 hours of continuous electroencephalography (EEG) between 2011 and 2017. We developed an artiﬁcial
intelligence algorithm to annotate 11.02 terabytes of EEG and quantify epileptiform activity burden within 72 hours of
recording. We evaluated burden (1) in the ﬁrst 24 hours of recording, (2) in the 12-hours epoch with highest burden
(peak burden), and (3) cumulatively through the ﬁrst 72 hours of monitoring. Machine learning was applied to estimate
the effect of epileptiform burden on outcome. Outcome measure was discharge modiﬁed Rankin Scale, dichotomized
as good (0–4) versus poor (5–6).
Results: Peak epileptiform burden was independently associated with poor outcomes (p < 0.0001). Other independent
associations included age, Acute Physiology and Chronic Health Evaluation II score, seizure on presentation, and diagnosis of hypoxic–ischemic encephalopathy. Model calibration error was calculated across 3 strata based on the time
interval between last EEG measurement (up to 72 hours of monitoring) and discharge: (1) <5 days between last measurement and discharge, 0.0941 (95% conﬁdence interval [CI] = 0.0706–0.1191); 5 to 10 days between last measurement and discharge, 0.0946 (95% CI = 0.0631–0.1290); >10 days between last measurement and discharge, 0.0998
(95% CI = 0.0698–0.1335). After adjusting for covariates, increase in peak epileptiform activity burden from 0 to 100%
increased the probability of poor outcome by 35%.
Interpretation: Automated measurement of peak epileptiform activity burden affords a convenient, consistent, and
quantiﬁable target for future multicenter randomized trials investigating whether suppressing epileptiform activity
improves outcomes.
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S

eizures and seizurelike periodic and rhythmic patterns
of brain activity (epileptiform activity [EA]) occur in
up to half of critically ill patients who undergo brain monitoring with electroencephalography (EEG).1–4 In small
focused cohorts, these patterns have been shown to be
associated with increased neurologic disability and mortality, with the probability of a poor outcome rising in
proportion to the burden of EA.1,2,4–8 However, the prognostic relevance of EA burden has not been quantiﬁed in
a large and heterogeneous cohort spanning the full range
of neurological, medical, and surgical illnesses. Analysis of
continuous EEG data and quantiﬁcation of EA burden on
a large scale not only for prognostic studies, but also for
potential therapeutic trials, have been limited by the timeconsuming nature of reviewing and annotating raw EEG.
In this study, we developed a novel automated
approach that enabled us to efﬁciently annotate all epileptiform patterns in a large set of continuous EEG recordings from acutely ill hospitalized patients. Using these
annotations, we developed a machine-learning model to
estimate the independent contribution of sustained exposure to EA to the level of neurologic disability at the time
of hospital discharge.

Patients and Methods
Study Design and Participants
We retrospectively identiﬁed medical, surgical, and neurological patients hospitalized between September 2011 and
February 2017 who underwent continuous EEG (cEEG)
monitoring at Massachusetts General Hospital. Patients
were admitted to medical, neurological, and surgical intensive care and general care units. We enrolled patients aged
18 years or older who underwent cEEG for at least
16 hours to monitor for seizure activity. We chose a
16-hour cutoff because prior work shows that the probability that seizures will occur if none has occurred after
16 hours of surveillance is <5%.9
We selected 2 groups of 1,000 patients each by
reviewing text reports of EEG ﬁndings in the electronic
health record. First, we selected 1,000 patients identiﬁed
by a clinical neurophysiologist or epileptologist as having
electrographic EA. Patterns included in our deﬁnition of
EA are deﬁned below. Second, we selected 1,000 consecutive patients who underwent at least 16 hours of cEEG
monitoring, independent of cEEG ﬁndings, to ensure
diversity in the cohort. We selected the 2 groups to
ensure we had both a representative sample of consecutive
patients, and also a representative sample of EA for model
building. Limiting the study to consecutive patients could
result in insufﬁcient epileptiform data points across the
large sample. Similarly, limiting the study to an enriched
August 2021

cohort of EA could reduce the diversity in the cohort.
The study team was blinded to outcomes and distribution
of EA burden in the cohort selection process.
A cohort size of 2,000 allowed us to include >200
patients within each of 4 disease subgroups (acute brain
injury, hypoxic–ischemic encephalopathy [HIE], acute seizures/status epilepticus in the absence of brain injury, and
primary systemic illness). Prior work in patients with subarachnoid hemorrhage shows that a mean electrographic
seizure burden of 6 hours (ie, a total of 6 hours of
recorded time spent seizing) is associated with approximately 60% probability of poor outcomes.6 Similarly, in
patients with subarachnoid hemorrhage, a maximum daily
EA burden of 6 hours was associated with approximately
60% probability of poor outcomes.7 Using this value for
mean EA burden, our sample size of 2,000 patients
(including at least 200 patients within each subgroup)
provided >90% power to detect a 15% increase in the
probability of poor outcomes in patients with EA burden
one standard deviation above the mean.
The study was approved by the local institutional
review board. The requirement for written informed consent was waived. The results are reported in accordance
with the STROBE (Strengthening the Reporting of
Observational Studies in Epidemiology) guidelines for
reporting observational studies (Appendix S1).10
Clinical Covariates
We abstracted clinical and demographic variables from
electronic health records. Clinical covariates included
admission diagnosis and premorbid medical conditions,
disease severity deﬁned by admission Glasgow Coma Scale
(GCS) and the Acute Physiology and Chronic Health
Evaluation II (APACHE II) scores, hospital-acquired
conditions (eg, hospital-acquired pneumonia, catheterassociated infections, venous thromboembolism), variables
extracted from diagnostic studies (neuroimaging reports,
laboratory tests), vital signs, and medications administered
throughout hospitalization. Variables with >1% missing
data were discarded, and missing values were imputed
with group medians for the rest.
Acquisition of cEEG Data
Clinical cEEG recordings were acquired according to an
institutional protocol applying a standard 21-electrode
montage with a physical reference electrode recorded over
Cz or posterior cervical spine (C2) according to the international 10–20 system.11 Signal quality (eg, lead maintenance and minimization of artifacts) was maintained by
twice-daily lead checks by EEG technicians, per routine
clinical care. All cEEG data were reviewed and reported
301
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clinically by 2 clinical neurophysiologists per our institutional standard of care.
We operationally deﬁned EA for this study as
electrographic seizures, periodic and rhythmic patterns
that are associated with seizures in critically ill patients or
associated with poor outcomes and likely to be treated
with antiepileptic drugs (AEDs).7,12 Periodic and rhythmic patterns were deﬁned using standardized nomenclature, including lateralized periodic discharges (LPDs),
bilateral independent periodic discharges, generalized periodic discharges (GPDs), and lateralized rhythmic delta
activity (LRDA).13 LRDA was included in our deﬁnition
of EA as it both confers a future seizure risk and is likely
to be treated.7,13 We excluded generalized rhythmic delta
activity (GRDA) from our deﬁnition of EA as prior studies suggest this pattern has minimal association with seizures or poor functional outcomes.7,12,14 Sporadic
epileptiform discharges were not included in our deﬁnition of EA. Examples of EA EEG patterns are shown in
Figure 1.

Automated Annotation and Quantiﬁcation of EA
Burden
To quantify the burden of EA in our patients, we developed a method to efﬁciently label large-scale cEEG
data.15,16 Extraction and processing of cEEG involved the
following steps:
1. Feature extraction from cEEG. All cEEG data were resampled to 200Hz and converted to longitudinal bipolar montage. The cEEG data were then divided into
2-second nonoverlapping segments. We then extracted
several features in the spectral and time domains
(eg, line length, kurtosis, entropy), as previously
described.16 To obtain information from the surrounding EEG, we also extracted these features in windows
of 6, 10, and 14 seconds centered on each 2-second
segment. The scalp spatial representation included
4 regions (left lateral, right lateral, left parasagittal, and
right parasagittal). After combining the spectral
and temporal features from all temporal scales and all
spatial regions, we had a total of 592 features that collectively describe each 2-second segment of cEEG.
2. Clustering cEEG data. We applied change point detection (CPD) with conservative settings on the total
power to divide cEEG data into homogeneous segments, that is, segments in which the EEG patterns
remain constant. We then used an unsupervised afﬁnity propagation plus bag-of-words–based model to cluster CPD-segmented cEEG data from each patient into
30 to 50 clusters.15,16
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3. Rapid manual cEEG annotation. A MATLAB
(MathWorks, Natick, MA)-based graphical user
interface was developed for experts (S.F.Z., E.S.R.,
M.B.W.) to score the medoid of each cluster. EEG
patterns were scored based on the American Clinical
Neurophysiology Society nomenclature as “Seizure,”
“LPD,” “GPD,” “LRDA,” or “GRDA”. EEG patterns
were labeled “Other” for any pattern (including background, artifact) that did not fall into any of the above
categories. With this scoring tool, experts generally
only need to label 30 to 50 cluster medoids per patient
to obtain high-quality labels for the entire EEG.
Nonmedoid cEEG samples automatically inherit the
labels from their medoids. The graphical user interface
used for this process is shown in Figure 2. We note
that the graphical display of clusters was not part of
the ﬁnal classiﬁcation of each event performed by the
trained model. Rather, clustering was an intermediate
step used as part of the process of gathering the labeled
samples that were used to train the model in the ﬁnal
step, described next.
4. Automated ﬁnal annotation. Finally, using the labels
created in the prior step, we trained a convolutional
neural network, and used this to label all EEG segments in the 2,000 EEG recordings consistently, at a
resolution of one annotation per 2 seconds.16
5. Calculation of EA burden. EA burden was calculated
within 72 hours of cEEG initiation. We evaluated the
following deﬁnitions of EA burden in our statistical
analysis:
1. EA burden over the ﬁrst 24 hours
2. Peak burden deﬁned as maximum EA burden captured within any 12-hour window in the ﬁrst
72 hours of recording
3. Cumulative EA burden over the ﬁrst 72 hours of
recording
We restricted calculation of EA burden to the ﬁrst
72 hours of recording to maintain homogeneity of the
exposure window.
Primary and Secondary Outcomes
We assessed the impact of EA burden on neurologic outcome at hospital discharge. Our primary outcome measure
was the modiﬁed Rankin Scale (mRS; 0, no symptoms;
1, no signiﬁcant disability; 2, slight disability; 3, moderate
disability; 4, moderate–severe disability; 5, severe disability; 6, death).17 The primary outcome was dichotomized,
and poor outcome was prespeciﬁed as a discharge mRS
score of 5 or 6 (vs 0–4).17 The secondary outcome measure was discharge Glasgow Outcome Scale Extended
(GOSE; 1, death; 2, vegetative state; 3, upper severe
Volume 90, No. 2
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FIGURE 1: Examples of epileptiform activity. Examples of normal electroencephalographic (EEG) background, seizure, and
periodic patterns are shown. Each EEG image shows a 10-second clip of recording in a longitudinal bipolar montage.
GPD = generalized periodic discharges; GRDA = generalized rhythmic delta activity; LPD = lateralized periodic discharges;
LRDA = lateralized rhythmic delta activity. [Color ﬁgure can be viewed at www.annalsofneurology.org]

disability; 4, lower severe disability; 5, upper moderate disability; 6, lower moderate disability—some disability but
can potentially return to some form of employment;
7, lower good recovery—minor physical or mental defect;
8, upper good recovery—full recovery). The secondary
outcome was dichotomized, and poor outcome was
prespeciﬁed as a discharge GOSE score of 1–4 (vs 5–8).18
We abstracted mRS and GOSE from physician and
physical therapy notes documented at the time of hospital
discharge. Outcomes were abstracted retrospectively and
adjudicated by independent reviewers (M.T., H.A.N.,
M.S., J.G., S.K., M.E., E.B.). During outcome
August 2021

abstraction, reviewers were blinded to EEG ﬁndings and
to antiseizure medication treatment status.
Statistical Analysis
Mean, median, and interquartile range were calculated for
descriptive analysis. Univariate analysis was performed
using a linear regression model, and signiﬁcance was set at
<0.05. We subtracted the GCS contribution from the
APACHE II score to compute the physiologic APACHE
II score, because GCS on admission and worst GCS in the
ﬁrst 24 hours were included separately as independent variables. Admission diagnosis was divided into 4 categories:
303
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FIGURE 2: Graphical user interface for electroencephalographic (EEG) annotation. Experts were asked to label the primary
pattern seen on the raw EEG clip (right). The spectrogram shown on the bottom left shows the 30-minute window from which
the raw EEG clip is taken. The map on the top left shows the distribution of epileptiform activity patterns labeled in the entire
recording. This map is an intermediate step, and updated as the model is trained and then classiﬁed. EKG = electrocardiogram;
GPD = generalized periodic discharges; GRDA = generalized rhythmic delta activity; LL = left lateral; LP = left parasagittal; LPD
= lateralized periodic discharges; LRDA = lateralized rhythmic delta activity; RL = right lateral; RP = right parasagittal. [Color
ﬁgure can be viewed at www.annalsofneurology.org]

(1) acute brain injury (any structural injury other than
HIE), (2) HIE, (3) acute seizures/status epilepticus in the
absence of acute structural brain injury or HIE, or (4) primary systemic illnesses without acute structural brain
injury or HIE.

Model Estimation and Validation
We created a multivariate logistic regression model using
EA burden, while adjusting for clinical variables as
covariates. We evaluated all 3 automated EA burden measures: EA burden over the ﬁrst 24 hours, peak burden
within 72 hours of recording start time, and cumulative
EA burden within the ﬁrst 72 hours. The covariates
included baseline clinical variables, measures of disease
severity, and variables with established associations with
outcome.19,20 These included age, gender, initial GCS,
worst GCS in the ﬁrst 24 hours, past history of acute
brain injury, history of epilepsy, cardiac arrest on presentation, seizure on presentation, and admission diagnosis:
(1) acute brain injury, (2) HIE, (3) acute seizures/status
epilepticus, (4) primary systemic illness.
304

For feature selection, we used L1 (least absolute
shrinkage and selection operator [LASSO]) regularization.21 We used 10-fold nested cross-validation (10-CV)
for feature selection. For each of the 10 rounds of 10-CV,
we split the data into training (90%) and test (10%) data.
For each fold of CV, the training data were further split
into training and internal validation data. Patients from
the enriched and consecutive cohorts were randomly distributed across the 10 folds during 10-CV, so that each of
the 10 folds included approximately 10% of patients from
each of the 2 groups. Models were ﬁt to the training for a
range of L1 regularization parameter values λ, and for each
value the performance was measured on the internal validation data. The globally optimal value of λ was selected
as the largest value such that deviance is within one standard error of the best average performance across the
10 folds. This optimal value was then used to train a single model on the entire training dataset. After model
ﬁtting on the training data, model calibration was assessed
on the test set. To account for differences in length of
stay, within the test set we stratiﬁed patients based on the
time interval between the last EEG measurement (within
Volume 90, No. 2
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FIGURE 3: First 24-hour epileptiform activity (EA) burden. (A) The ﬁrst 24 hours of continuous electroencephalographic recording
for all patients is shown. The x-axis shows hours of recording, and the y-axis shows individual patients. The shading/color codes
represent different EA patterns. (B) A magniﬁed view of the upper left corner is shown to demonstrate the hour-by-hour pattern
type and burden in the ﬁrst 3 hours. GPD = generalized periodic discharges; GRDA = generalized rhythmic delta activity;
LPD = lateralized periodic discharges; LRDA = lateralized rhythmic delta activity. [Color ﬁgure can be viewed at www.
annalsofneurology.org]

up to 72 hours of monitoring) and discharge. The test set
was stratiﬁed into 3 groups: (1) <5 days between last EEG
measurement and discharge, (2) 5 to 10 days between last
EEG measurement and discharge, (3) >10 days between
last EEG measurement and discharge. We combined the
features selected from each fold and selected 9 features in
the ﬁnal model. We performed 10,000 rounds of bootstrapping to obtain conﬁdence bounds on model calibration error.
Subgroup Analyses
We developed regression models using the features
selected in our overall model to quantify the association of
EA burden with outcomes within each of the 4 diagnostic
categories: (1) acute brain injury (any structural injury
other than hypoxic–ischemic injury), (2) HIE, (3) acute
seizures/status epilepticus in the absence of acute structural brain injury or HIE, or (4) primary systemic illnesses
without acute structural brain injury or HIE.

Results
Of 2,000 patients initially included in the study, 33 were
excluded due to corrupted cEEG ﬁles or <16 hours of
interpretable cEEG recording. Demographic and clinical
variables for 1,967 patients are summarized in Table S1.
The median age was 62 years, and 48% (n = 950) of
patients were female. The median physiologic APACHE
II score was 10, and the median GCS on admission was
11. Most patients had a primary diagnosis of acute brain
injury (n = 1,194, 60.7%), followed by seizures/status
epilepticus (n = 279, 14.2%) and primary systemic illness
(n = 246, 12.5%). A total of 429 (21.8%) had clinical
seizures at admission. Fifty-nine percent (n = 1,160) of
August 2021

patients received AED treatment. Discharge mortality was
25.7% (n = 506).
We annotated EA in 11.02 terabytes of EEG data.
Ninety-nine percent (n = 1,953) had EA patterns on
cEEG monitoring. The median duration of cEEG monitoring was 52 hours. Figure 3 shows a swimmer plot summarizing EEG patterns from the ﬁrst 24 hours across all
patients. For patients with 16 to 23 hours of cEEG
recording (n = 110), all available cEEG data were considered as the ﬁrst 24-hour epoch. Peak EA burden was calculated within 72 hours of recording initiation, and
deﬁned as maximum EA burden captured within any
12-hour window. Peak EA burden was calculated as the
percentage of the 12-hour epoch occupied by EA patterns.
For patients with <72 hours of recording, all available
cEEG data were considered for calculation of peak burden. Figure 4 shows examples of varying peak EA
burdens. A peak EA burden of 100% means the entire
12-hour window is continuously occupied by EAs. In
other words, a 0 to 100% increase in peak EA burden
means going from absent or zero EA in the 12-hour epoch
to continuous EA present throughout the entire 12-hour
epoch. The median time from initiation of cEEG to peak
burden was 21 hours (interquartile range = 8–38), and
1,627 (85%) patients had their peak burden within
48 hours of monitoring.
We examined the inter-rater agreement for EEG patterns between clinical neurophysiologists, and between
clinical neurophysiologists and machine annotations. The
average percent agreement between expert raters for
the different EEG patterns was as follows: Seizures,
88.7%; LPDs, 87.6%; GPDs, 92.6%; LRDA, 89.8%;
GRDA, 87.6%. The average percent agreement between
305
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FIGURE 4: Peak epileptiform activity burden. Twelve-hour spectrogram windows with representative 15-second raw
electroencephalogram (EEG) clips are shown. Spectrogram panels from top to bottom show left lateral (LL), right lateral (RL), left
parasagittal (LP), and right parasagittal (RP) regions. The triangular marker on top of the spectrogram panels denotes the region
from where the raw EEG clip is taken. The raw EEG image shows a 15-second clip of recording in a longitudinal bipolar montage.
(Figure legend continues on next page.)
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TABLE. Variables Associated with Poor Outcome (Modiﬁed Rankin Scale = 5–6)
Univariate Analysis
Regression
Coefﬁcient [95% CI]a

p

EA burden, initial 24 h

1.715 [1.239 to 2.192]

<0.0001

Peak burden (maximum 12-h EA burden)

1.856 [1.226 to 21.894]

<0.0001

Cumulative burden (EA burden over the entire recording)

2.133 [1.598 to 2.192]

<0.0001

Age

0.018 [0.013 to 0.024]

<0.0001

Initial GCS

0.104 [ 0.124 to –0.085]

<0.0001

Worst GCS, initial 24 h

0.102 [ 0.121 to –0.084]

<0.0001

APACHE II

0.109 [0.093 to 0.124]

<0.0001

History of epilepsy

0.657 [ 0.890 to –0.423]

<0.0001

Cardiac arrest on presentation

1.237 [0.931 to 1.542]

<0.0001

Seizure on presentation

0.638 [ 0.858 to –0.419]

<0.0001

Primary diagnosis of HIE

1.727 [1.374 to 2.080]

<0.0001

Primary diagnosis of acute SZ/SE

0.912 [ 1.182 to –0.642]

<0.0001

Covariate

Multivariate Analysis
Folds in Which
Feature Selected, nb

Regression
Coefﬁcient [95% CI]

p

Peak burden (maximum 12-h EA burden)

10

1.470 [1.099 to 1.841]

<0.0001

Age

10

0.017 [0.011 to 0.023]

<0.0001

Initial GCS

10

0.038 [ 0.079 to –0.003]

0.070

Worst GCS, initial 24 h

10

0.056 [ 0.094 to –0.018]

0.004

APACHE II

10

0.072 [0.055 to 0.088]

Covariate

History of epilepsy

<0.0001

6

0.119 [ 0.400 to 0.161]

0.400

Seizure on presentation

10

0.612 [ 0.888 to –0.335]

<0.0001

Primary diagnosis of HIE

10

1.185 [0.792 to 1.579]

<0.0001

Primary diagnosis of acute SZ/SE

10

0.385 [ 0.719 to –0.053]

0.02

a

For predictors with a positive regression coefﬁcient, presence/higher value is associated with higher probability of poor outcome. For predictors with a
negative regression coefﬁcient, presence/higher value is associated with lower probability of poor outcome.
b
For multivariate analysis, the number of folds of cross-validation in which each feature was selected is shown.
APACHE II = Acute Physiology and Chronic Health Evaluation II; CI = conﬁdence interval; EA = epileptiform activity; GCS = Glasgow Coma
Scale score; HIE = hypoxic–ischemic encephalopathy; SZ/SE = acute seizures/status epilepticus.

Peak epileptiform activity (EA) burden was deﬁned as the maximum burden captured within any 12-hour window, and measured as
the percentage of the 12-hour epoch occupied by EA patterns. The peak EA burden was measured within 72 hours of recording.
(A) Peak EA burden of 0%. The spectrogram is characterized by nonsustained <5Hz band of high power. The raw EEG clip shows
generalized slowing without epileptiform activity. (B) Peak EA burden of 50%. The spectrogram is characterized by appearance of
spectrogram segments with high power and bandwidth, irregularly rising up from the delta range into the theta range. The raw
EEG shows right-sided periodic discharges. (C) Peak EA burden of 100%. The spectrogram is characterized by sustained higher
power at low frequencies, with minimal variation or very gradual waxing and waning of frequencies within the high-power band.
The raw EEG clip shows continuous epileptiform activity over the right hemisphere, characterized by spikes and spikes and slow
waves with evolving frequency. EKG = electrocardiogram. [Color ﬁgure can be viewed at www.annalsofneurology.org]
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FIGURE 5: Modeled performance: calibration curves. Model
calibration curves across the 3 strata of time intervals
between measurement of peak epileptiform activity and
discharge are shown. The mean calibration errors (CEs) for
the multivariate outcome model across the 3 strata were as
follows: (1) <5 days between last electroencephalographic
(EEG) measurement and discharge, 0.0941 (95% conﬁdence
interval [CI] = 0.0706–0.1191); (2) 5 to 10 days between last
EEG measurement and discharge, 0.0946 (95% CI = 0.0631–
0.1290); (3) >10 days between last EEG measurement and
discharge, 0.0998 (95% CI = 0.0698–0.1335). [Color ﬁgure
can be viewed at www.annalsofneurology.org]

expert raters and the machine learning model for the different EEG patterns as was follows: Seizures, 88.8%;
LPDs, 85.4%; GPDs, 92.7%; LRDA, 92.5%; GRDA,
90.1%. Thus, on average, the model agrees with experts
at least as well as they agree with one another as to the
class of epileptiform abnormalities.
Primary Outcome (mRS = 5–6)
Signiﬁcant associations with poor outcome (mRS = 5–6)
on univariate analysis are shown in the Table. All 3 measures of automated EA burden (ﬁrst 24-hour burden, peak
burden, and cumulative burden) were signiﬁcantly associated with poor outcome. Other signiﬁcant associations
included primary diagnosis of HIE, age, and physiologic
APACHE II score.
Nine features were selected by LASSO regularization
and cross-validation to be included in the ﬁnal multivariate model (see Table). Outcomes and EA burden were
evenly distributed across the training and testing samples
and across the 10 folds of CV. Across the 10 folds, the
average percentage of good outcomes was 51% in
the training and 51% in the testing data. The distribution
of EA burden was similar across the 10 folds, and differed
between good and poor outcome groups primarily at the
extremes; the good outcome group had relatively more
308

FIGURE 6: Dose–response relation between peak
epileptiform activity (EA) burden and outcomes. The ﬁgure
shows the modeled probability of poor outcome (modiﬁed
Rankin Scale = 5–6) with increasing peak burden (maximum
EA burden captured within any 12-hour window). This dose–
response plot is obtained from the multivariate model that
included the ﬁnal 9 covariates: age, initial Glasgow Coma
Scale (GCS), worst GCS in the ﬁrst 24 hours, Acute
Physiology and Chronic Health Evaluation II score, history of
epilepsy, seizure on presentation, primary diagnosis of
hypoxic–ischemic encephalopathy, primary diagnosis of
acute seizure/status epilepticus, and peak burden. The
shaded areas represent the 95% conﬁdence intervals of the
model output. Increasing the peak EA burden from 0 to
100% increases the probability of a poor outcome by
approximately 35% across all strata. The median value of
other covariates is used to build the curve. [Color ﬁgure can
be viewed at www.annalsofneurology.org]

patients with low (<0.1) EA burden, and the poor outcome group had relatively more patients with high (>0.9)
EA burden. The median peak burden in patients with
poor outcomes across the 10 folds was 0.11 (Q1–
Q3 = 0.01–0.1), and the median peak burden in patients
with good outcomes across the 10 folds was 0.04 (Q1–
Q3 = 0.03–0.05).
Among automated EA burden measures, the peak
burden (maximum burden in any 12-hour window measured in the ﬁrst 72 hours) was selected, and had a coefﬁcient value in the ﬁnal multivariate model of 1.470 (95%
CI = 1.099–1.841, p < 0.0001), demonstrating a strong
independent association with poor outcome. The mean
calibration errors for the multivariate outcome model
across the 3 strata were as follows: (1) discharge <5 days
after last EEG measurement, 0.0941 (95% CI = 0.0706–
0.1191); (2) discharge 5 to 10 days after last EEG measurement, 0.0946 (95% CI = 0.0631–0.1290); (3) discharge >10 days after last EEG measurement, 0.0998
(95% CI = 0.0698–0.1335). The mean calibration errors
indicate good agreement between model-estimated and
observed risk across all 3 strata (Fig 5). Figure 6 shows the
probability of poor outcome as a function of increasing
EA burden. Increasing the peak EA burden from 0 to
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FIGURE 7: Dose–response relation between epileptiform activity burden and outcome in subgroup analysis. (A) Among patients
with acute brain injury (ABI), there was a 20 to 30% increase in the probability of poor outcome comparing patients with peak
epileptiform activity (EA) burden of 0 versus 100%. (B) Among patients with hypoxic–ischemic encephalopathy (HIE), there was a
60 to 70% increase in the probability of poor outcome comparing patients with peak EA burden of 0 versus 100%. (C) Among
patients with acute seizures/status epilepticus (SZ/SE), there was a 50% increase in the probability of poor outcome comparing
patients with peak EA burden of 0 versus 100%. (D) Among patients with primary systemic illness, there was a 10 to 20%
increase in the probability of poor outcome comparing patients with peak EA burden of 0 versus 100%. [Color ﬁgure can be
viewed at www.annalsofneurology.org]

100% increased the probability of a poor neurologic outcome by approximately 35% across the 3 strata.

>10 days between last EEG measurement and discharge,
0.1367 (95% CI = 0.0891–0.1857).

Secondary Outcomes (GOSE = 1–4)
Among automated EA burden measures, the peak burden
(maximum burden in any 12-hour window) was selected
10 of 10 times as a covariate associated with poor outcome. The multivariate outcome model yielded results
similar to the primary outcome of mRS, with the following mean calibration errors: (1) <5 days between last EEG
measurement and discharge, 0.1184 (95% CI = 0.0817–
0.1586); (2) 5 to 10 days between last EEG measurement
and discharge, 0.1405 (95% CI = 0.0686–0.2193); (3)

Subgroup Analysis
A dose-dependent association between peak EA burden
and poor outcomes was seen across all diagnostic categories, that is, acute brain injury, HIE, acute seizures/status
epilepticus, and primary systemic illness (Fig 7). This association was highest for patients with HIE across all 3 strata
(average 65% increase in the probability of poor outcome
when comparing patients with peak EA burden of 0 vs
100%), followed by patients with seizures/status
epilepticus (average 50% increase in probability of poor
outcome with increasing peak EA burden). Among
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patients with acute brain injury, there was an average
30% increase in the probability of poor outcome comparing patients with EA burden of 0 versus 100% across all
3 strata. In patients with primary systemic illness, there
was an average 15% increase in the probability of poor
outcome comparing patients with EA burden of 0 versus
100% across all 3 strata.

Discussion
Using automated EEG labeling, we efﬁciently quantiﬁed
EA burden in a large cohort of patients across a wide variety of diagnoses. We found that an increasing EA burden
is associated with worse neurologic outcomes at hospital
discharge. Speciﬁcally, peak (maximum 12-hour) EA burden is associated with worse outcomes in a dosedependent manner. Other factors being equal, increasing
peak EA burden from 0 to 100% increases the probability
of poor neurologic outcome by 35%. This dose–response
relation is seen independently of the time interval between
the last EEG measurement and discharge.
Increasing burden of electrographic seizures has been
shown to be associated with worse outcomes in prior studies.6,22 A prospective cohort of pediatric critically ill
patients found that a seizure burden threshold of >20%
(12 minutes) per hour was associated with worse neurologic outcomes.22 In subarachnoid hemorrhage patients,
increasing seizure burden is similarly associated with worse
outcomes, as is increasing burden of seizurelike rhythmic
and periodic EEG patterns.6,7 In a more recent study of
moderate–severe traumatic brain injury patients, although
the burden of EAs was associated with disease severity, the
authors did not ﬁnd any association with 3-month functional outcomes.23 However, the authors evaluated average
burden, and did not quantify the peak burden. This work
builds on that by demonstrating that high intensity of
EAs (highest peak burden) may be of greater importance
compared with the overall or cumulative burden of EAs.
Both seizures and periodic EEG patterns are associated with increased cerebral metabolism.24 In traumatic
brain injury patients, seizures and periodic discharges are
associated with low brain glucose and elevated microdialysis lactate/pyruvate ratios, a condition described as
metabolic crisis.25 This mismatch between metabolic supply and demand may be a driver of worse outcomes seen
with increasing EA burden.
Although the dose-dependent relationship between
EA burden and poor outcomes in our cohort was present
across diagnostic categories, a greater effect was seen in
patients who presented with clinical seizures/status
epilepticus, compared to patients with acute brain injuries.
This ﬁnding is similar to the ﬁnding in pediatric critically
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ill patients, where the association between seizure burden
and neurological decline was stronger in patients with
acute seizures than in patients with acute brain injury. Seizures on presentation were associated with better outcomes, likely because many of these patients had
established epilepsy presenting with breakthrough seizures,
and therefore had lower illness severity, less comorbid heterogeneity, and a lower baseline probability of poor
outcomes.
Limitations of our study include its retrospective
design and performance at a single center. We assessed
outcomes at discharge rather than in the long term,
whereas functional outcomes can continue to evolve after
discharge. Additionally, cognitive outcomes were not
assessed, and should be evaluated in future studies.
Although half the patients in our cohort received AED
treatment, we did not include AEDs in our outcome
model as we considered them to be a part of the causal
pathway linking EA burden to outcomes. Investigating the
impact of AED treatment is also limited by confounding
by indication. Future controlled prospective studies that
address these challenges are needed to determine whether
treatment with AEDs improves outcomes.
EA burden is associated with worse neurologic outcomes in medical, neurologic, and surgical patients. Peak
or maximum EA burden is thus a promising target for
future multicenter randomized controlled trials investigating whether suppressing such activity can improve neurologic outcomes. The automated method for EEG labeling
and quantiﬁcation of EA burden has a future role in the
high-throughput assessment of candidate therapies. As a
next step, this tool has applications in studies investigating
the long-term impact of EA on functional and cognitive
outcomes, and the longitudinal effect of antiseizure
treatment.
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